Effects Of A Sativex-Like Combination Of Phytocannabinoids On Disease Progression In R6/2 Mice, An Experimental Model Of Huntington’s Disease

Key Findings

A Sativex-like combination of phytocannabinoids administered to R6/2 mice at the onset of motor symptoms produced certain benefits on the progression of striatal deterioration in these mice, which supports the interest of this cannabinoid-based medicine for the treatment of disease progression in HD patients.